Regeneron Pharmaceuticals Inc (REGN)

Overview News Price History Option Chain Financials Why REGN Down? Discussions Forecast

Regeneron Pharmaceuticals Inc Stock (REGN) Financials Data

*All numbers in millions

Period End Date	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
Revenues	8.42% 3,145.00	3,434.30	3,362.70	3,158.10	3,162.10
Operating Expenses	2.75% 2,393.60	2,461.40	2,251.70	2,141.60	2,215.40
Interest Income/Expense	12.02% 16.10	18.30	17.80	18.90	18.00
Benefits Costs and Expenses	6.89% 2,444.30	2,286.70	2,251.90	2,075.20	2,304.10
Costs And Expenses	2.75% 2,393.60	2,461.40	2,251.70	2,141.60	2,215.40
Operating Income/Loss	22.77% 751.40	972.90	1,111.00	1,016.50	946.70
Nonoperating Income/Loss	129.02% -50.70	174.70	-0.20	66.40	-88.70
Income/Loss From Continuing Operations Before Tax	38.94% 700.70	1,147.60	1,110.80	1,082.90	858.00
Income Tax Expense/Benefit	77.50% -21.30	-12.00	103.00	114.50	40.20
Income/Loss From Continuing Operations After Tax	37.74% 722.00	1,159.60	1,007.80	968.40	817.80
Net Income/Loss	37.74% 722.00	1,159.60	1,007.80	968.40	817.80
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	107.90K% 107.80	-0.10	106.30	107.00	107.10
Diluted Average Shares	115.10	-	113.40	113.90	114.00
Basic Earnings Per Share	38.48% 6.70	10.89	9.48	9.05	7.64
Diluted Earnings Per Share	38.53% 6.27	10.20	8.89	8.50	7.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

VRTX

$464.56

0.54%

ARGX

$614.59

1.22%

ALNY

$253.74

0.15%

BNTX

$120.72

1.84%

BGNE

$206.16

7.31%